I agree the is no overarching conspiracy at the FDA, but that said there is also no incentive to ever actually DO anything. If Cytodyn presents good safety data then the FDA is exposing itself to a lawsuit only if the FDA looks at the data which could take years while the individual is still getting paid. And every go around option takes years. Even then I have never heard of Fed employee being hurt by being incompetent. Then there is the constant turn over. That's why Cyrus needs inside help. This is why in the CC this Cyrus statement is the most important:
"And during my time as a consultant, I worked with nearly all of the top 40 large cap and mid cap biopharmaceutical developers. I've seen the drug development process from end to end. And I have had the opportunity to look at over 1,000 clinical development programs across hundreds of different molecules. And, importantly, I have had the benefit of time, to see how these programs have actually played out, either in the clinic or in the markets. I have looked at these molecules through the lens of an investor, developer, a competitor or in some cases as an acquirer. Through these experiences, I've learned extensively about what the hall marks are for a clinical phase therapeutic to get to market."